← Scoopfeeds — Intelligent news, curated.
Telix gets FDA alignment on prostate cancer trial expansion to US
business

Telix gets FDA alignment on prostate cancer trial expansion to US

Investing.com · Jul 2, 2026, 1:37 AM · Also reported by 1 other source

Telix gets FDA alignment on prostate cancer trial expansion to US

Read full story on Investing.com → More top stories

Also covered by

Healthline HHS to Update Testosterone Therapy Labels for Prostate Cancer, Hypogonadism

More in business

Bloomberg Markets
Citi's Luet: China's Franchise Has Grown Very Strongly
Investing.com
Apple to launch at least 5 new iPhone models through early 2027, Nikkei reports
Investing.com
Exclusive-Japan shifts to ambush intervention tactics against yen short sellers, sources say
Bloomberg Markets
Japan 10-Year Bond Sale Sees Weaker Demand Than 12-Month Average
Investing.com
Bain, LY Corp submit binding bid for Kakaku, escalating takeover battle
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop